GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Cosmos Pharmaceutical 3349.T · JPY

Consumer Staples · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

6,405

+1.03%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥1.10trn

FY2017FY2026

Net income

¥32.05bn

FY2017FY2026

Free cash flow

−¥11.67bn

FY2017FY2026

Shareholders' equity

¥283.70bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥1.10trn¥1.01trn¥964.99bn¥827.70bn¥755.41bn¥726.42bn¥684.40bn¥611.14bn¥558.00bn¥502.73bn
Gross profit¥229.68bn¥213.28bn¥188.31bn¥168.72bn¥151.45bn¥145.11bn¥134.98bn¥121.78bn¥110.32bn¥100.04bn
Operating income¥42.35bn¥40.40bn¥31.50bn¥30.13bn¥29.80bn¥33.15bn¥29.09bn¥24.77bn¥22.75bn¥22.24bn
Net income¥32.05bn¥30.98bn¥24.45bn¥23.80bn¥23.16bn¥27.16bn¥21.43bn¥19.18bn¥17.63bn¥18.21bn
Diluted earnings per share404.33390.85308.54300.29292.37342.89270.65242.24222.64229.99

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥596.49bn¥525.17bn¥476.98bn¥421.41bn¥363.50bn¥341.78bn¥320.78bn¥274.08bn¥251.19bn¥225.69bn
Cash and short-term investments¥61.34bn¥57.04bn¥52.30bn¥45.93bn¥37.36bn¥55.11bn¥52.12bn¥19.02bn¥21.67bn¥27.73bn
Total liabilities¥312.78bn¥267.71bn¥245.53bn¥210.33bn¥172.99bn¥171.20bn¥175.10bn¥147.79bn¥142.30bn¥132.64bn
Debt¥78.48bn¥49.96bn¥34.06bn¥18.20bn¥9.41bn¥10.44bn¥12.12bn¥13.88bn¥17.20bn¥21.77bn
Shareholders' equity¥283.70bn¥257.46bn¥231.44bn¥211.07bn¥190.51bn¥170.58bn¥145.68bn¥126.29bn¥108.89bn¥93.05bn
Shares outstanding79m79m79m79m79m79m79m79m79m79m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations¥58.79bn¥52.47bn¥52.47bn¥55.17bn¥54.43bn¥32.19bn¥27.88bn¥65.46bn¥34.38bn¥32.59bn
Capital spending−¥70.46bn−¥53.33bn−¥53.33bn−¥55.81bn−¥46.64bn−¥43.50bn−¥26.06bn−¥25.95bn−¥29.04bn−¥29.45bn
Free cash flow−¥11.67bn−¥859.0m−¥859.0m−¥635.0m¥7.80bn−¥11.30bn¥1.81bn¥39.51bn¥5.34bn¥3.13bn
Dividends paid−¥5.94bn−¥4.96bn−¥4.96bn−¥4.66bn−¥3.27bn−¥3.27bn−¥2.28bn−¥2.08bn−¥1.78bn−¥1.78bn

Latest quarters

By quarter end

Aug 2026May 2026Feb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024
Revenue¥286.65bn¥289.20bn¥273.20bn¥264.78bn¥272.39bn¥259.12bn¥246.33bn¥244.09bn
Gross profit¥62.13bn¥59.74bn¥57.06bn¥55.71bn¥57.17bn¥54.07bn¥53.13bn¥51.51bn
Operating income¥12.01bn¥10.33bn¥11.35bn¥9.03bn¥11.64bn¥8.78bn¥11.28bn¥8.76bn
Net income¥8.25bn¥9.30bn¥8.10bn¥6.48bn¥8.17bn¥8.63bn¥7.92bn¥6.29bn
Diluted earnings per share104.10117.31102.2081.72103.09108.9599.8679.30
Cash from operations—¥58.79bn——————
Capital spending—−¥70.46bn——————
Free cash flow—−¥11.67bn——————
Total assets¥590.56bn¥596.49bn¥546.75bn¥542.74bn¥524.30bn¥525.17bn¥474.10bn¥486.57bn
Cash and short-term investments¥39.38bn¥61.34bn¥30.88bn¥43.24bn¥49.54bn¥57.04bn¥22.77bn¥39.13bn
Debt¥8.78bn¥73.19bn¥17.38bn¥40.10bn¥5.48bn¥45.14bn¥8.01bn¥25.68bn
Shareholders' equity¥288.41bn¥283.70bn¥274.25bn¥269.13bn¥262.66bn¥257.46bn¥248.82bn¥243.49bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue9.9%8.6%9.4%
Operating income12.0%5.0%8.5%
Net income10.4%3.4%9.9%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin21.0%20.5%20.4%20.2%
Operating margin3.9%3.7%3.8%4.0%
Net margin3.0%2.9%3.0%3.1%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings16.420.321.727.122.824.730.811.610.312.8
Price to sales0.50.60.60.80.70.91.00.40.30.5

Dividends and splits

Per share, in the currency the company pays

Paid for 21 years. Last went ex-dividend on 28 May 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year82.00100.0058.7541.2533.7528.7526.2522.50
  • 2-for-1 split · 29 Aug 2024
  • 2-for-1 split · 28 May 2020
  • 2-for-1 split · 25 Nov 2005

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.